WINNER 2025

Dr. Abhijit Ray Celebrates 2025 Global Recognition Award™

Global Recognition Awards

Dr. Abhijit Ray Receives 2025 Global Recognition Award™

Dr. Abhijit Ray, a leading cardiologist and healthcare innovator, has been recognized with a 2025 Global Recognition Award for developing breakthrough innovations in cardiac healthcare diagnostics. His patented formula measures left ventricular ejection fraction (LVEF) from ECG readings, significantly improving heart failure screening accessibility and cost-effectiveness for 64 million people worldwide. Dr. Ray combines medical expertise with technological solutions to create practical healthcare improvements. His background includes medical training in India, MRCP(UK) certification, and advanced cardiology studies at Harvard Medical School, establishing his comprehensive understanding of global healthcare needs and technological possibilities.

Healthcare Innovation Impact

Dr. Ray’s patented formula, recognized by the USPTO (patent number 11517204B2), enables healthcare providers to obtain precise left ventricular ejection fraction measurements from standard ECG readings. The method reduces dependency on expensive imaging procedures, making vital cardiac diagnostics available across diverse healthcare settings. Healthcare providers can now identify heart failure risks efficiently, leading to earlier interventions. This innovation benefits medical facilities in resource-limited areas where traditional diagnostic equipment might be unavailable or financially prohibitive.

The “One Nation One ECG” campaign across India demonstrates the practical benefits of this innovation. The initiative has screened over 3,500 patients using hand-held ECG devices, showing strong adoption and effectiveness. “This campaign represents a significant improvement in heart failure screening, bringing advanced cardiac diagnostics to underserved communities,” notes the award committee. The program’s success validates the scalability of Dr. Ray’s innovation and its potential for implementation in other regions facing similar healthcare challenges. Medical professionals report improved diagnostic capabilities and reduced waiting times for cardiac assessments, leading to faster treatment decisions.

Research Contributions and Healthcare Advancement

Dr. Ray’s research team developed the concept of Impending Heart Failure, which is now under evaluation for inclusion in WHO ICD-11, marking progress in preventive cardiology. He created an algorithm to predict Dengue Shock Syndrome risk, showcasing his broader contributions to healthcare challenges. These developments reflect his systematic approach to medical innovation. His research methodology combines clinical observations with data analysis, resulting in practical diagnostic tools that address multiple healthcare challenges. The pending WHO recognition of Impending Heart Failure highlights the scientific community’s validation of his work.

His research includes important studies on ECG-based serum potassium estimation and the relationship between PCOS and heart failure. Dr. Ray’s work establishes new methods for diagnosis and treatment in cardiovascular medicine, supported by clinical evidence and practical applications. Publications in respected medical journals document his findings on hypertension in post-COVID syndrome and the potential increased risk of COVID-19 with proton pump inhibitors. Each study demonstrates his commitment to addressing emerging healthcare challenges while maintaining scientific rigor.

Final Words

Dr. Ray’s medical innovations demonstrate effective solutions for improving cardiac diagnostics. His work makes advanced cardiac screening possible in regions where medical imaging remains inaccessible or expensive. The LVEF formula provides reliable diagnostic capabilities while reducing healthcare costs. Medical facilities worldwide report successful implementation of his methods, leading to improved patient outcomes and more efficient resource allocation. The innovation’s impact extends beyond individual diagnosis to public health planning and preventive medicine strategies.

The selection committee recognized Dr. Ray’s successful implementation of the “One Nation One ECG” campaign, which delivers measurable healthcare benefits. His ongoing research into post-COVID complications and preventive cardiology continues to contribute practical solutions to global healthcare challenges. The combination of scientific innovation and practical implementation demonstrates his comprehensive approach to healthcare improvement. Medical professionals globally acknowledge the value of his contributions to clinical practice and research methodology.

ADDITIONAL INFORMATION

Table Header Table Header

Industry

Healthcare

Location

New Delhi, India

What They Do

Dr. Abhijit Ray is a cardiologist and healthcare innovator who developed an innovative method to measure left ventricular ejection fraction (LVEF) from ECG readings, making heart failure screening more accessible and cost-effective. He holds patent #11517204B2 for this innovation, which reduces reliance on expensive imaging procedures. He led the “One Nation One ECG” campaign in India, screening over 3,500 patients. Dr. Ray also developed the concept of Impending Heart Failure (under WHO ICD-11 evaluation) and created an algorithm to predict Dengue Shock Syndrome risk. His work combines medical expertise with technological solutions to improve global healthcare accessibility.

Website

Take your business to the next level

Apply today and be a winner